---
figid: PMC8565990__JEP-13-923-g0001
figtitle: 'BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical
  View'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Canis lupus familiaris
- Severe acute respiratory syndrome coronavirus 2
- Erebia epipsodea
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Canis lupus familiaris
- Danio rerio
pmcid: PMC8565990
filename: JEP-13-923-g0001.jpg
figlink: /pmc/articles/PMC8565990/figure/f0001/
number: F1
caption: B Cell Receptor Signaling Pathway and Inhibition of BTK. Surface membrane
  of a B cell demonstrating surface B cell receptor and down-stream signaling molecules
  that participate in providing pro-survival, proliferation, migration, and apoptosis
  signals to the B cell, including CLL cells. Inhibitors of BTK that block this signaling
  are shown below, including inducers of degradation, irreversible and reversible
  inhibitors of BTK kinase activity.
papertitle: 'The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia:
  A Clinical View.'
reftext: Francesco Paolo Tambaro, et al. J Exp Pharmacol. 2021;13:923-935.
year: '2021'
doi: 10.2147/JEP.S265284
journal_title: Journal of Experimental Pharmacology
journal_nlm_ta: J Exp Pharmacol
publisher_name: Dove
keywords: chronic lymphocytic leukemia | CLL | Brutonâ€™s tyrosine kinase | BTK | targeted
  therapy | ibrutinib | acalabrutinib | pirtobrutinib
automl_pathway: 0.8667451
figid_alias: PMC8565990__F1
figtype: Figure
redirect_from: /figures/PMC8565990__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8565990__JEP-13-923-g0001.html
  '@type': Dataset
  description: B Cell Receptor Signaling Pathway and Inhibition of BTK. Surface membrane
    of a B cell demonstrating surface B cell receptor and down-stream signaling molecules
    that participate in providing pro-survival, proliferation, migration, and apoptosis
    signals to the B cell, including CLL cells. Inhibitors of BTK that block this
    signaling are shown below, including inducers of degradation, irreversible and
    reversible inhibitors of BTK kinase activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BTK
  - CD79A
  - CD79B
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - LYN
  - SYK
  - BLNK
  - IBTK
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CD19
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - NFKB1
  - MTOR
  - Btk
  - Cd79a
  - Cd79b
  - Lyn
  - Syk
  - Blnk
  - Ibtk
  - Plcg2
  - Cd19
  - Pik3r1
  - Ephb2
  - Mapk1
  - Akt1
  - Nfkb1
  - Mtor
  - Prkcg
  - Pik3cg
  - Ephb1
  - btk
  - kita
  - ngfra
  - cd79a
  - cd79b
  - lyn
  - si:ch73-206d17.1
  - syk
  - blnk
  - plcg2
  - ighv1-1
  - mtor
---
